Back

Comparative evaluation of handheld 6-lead and standard 12-lead electrocardiograms in patients with arrhythmia

14 April 2026 (08:00 - 14:45)
Organised by: Logo
Congress Presentation Part of: Poster session (3): mechanisms and management of arrhythmias m-Health & Mobile Apps EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Associate Professor Young Jun Park

Korea University Anam Hospital, Seoul (Korea (Republic of))

188 More presentations in this session

Presentation thumbnail
Comparison of ECG findings between young patients with cryptogenic ischemic stroke and stroke-free control subjects
Doctor J. Uutela (Jyvaskyla, FI)
Abstract
Presentation thumbnail
A wearable SCG-based approach for early, low-cost screening of valvular heart disease
Doctor V. Pergola (Naples, IT)
Presentation thumbnail
Intraoperative assessment of cardiac parasympathetic tone using short-term HRV metrics before and after atropine administration: a pilot study
Doctor B. Hrymniak (Wroclaw, PL)
Abstract
Presentation thumbnail
Arrhythmia phenotypes in hair-loss therapies: insights from minoxidil and finasteride reports in eudravigilance
Doctor Y. Shhab (Bucharest, RO)
Abstract
Presentation thumbnail
Arrhythmias and device therapy in HFpEF: Insights from a real-world hospital cohort
Ms A. Bondoc (Timisoara, RO)
Abstract Slides Video

Access the full session

Session thumbnail
Poster session (3): mechanisms and management of arrhythmias

The Event

Event poster

EHRA 2026

14 April 2026 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Unveiling the superiority of 6-lead consumer-grade ECG: a comparative study on arrhythmia detection and numerical accuracy
thumbnail
Congress Presentation
Comparative analysis of 6-Lead and single lead consumer-grade electrocardiograms: diagnostic accuracy, numerical agreement, and inter-rater reliability
thumbnail
Congress Presentation
Effectiveness of 6-lead consumer-grade ECG monitoring on the detection of newly diagnosed arrhythmias in patients taking proarrhythmic medications: an interim analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources